1
SEMPERIT GROUP
INVESTOR PRESENTATION
Q1 2014
20 May 2014
Operational Development (p. 3)
Outlook (p. 12)
Appendix (p. 15)
Agenda
2 Investor Presentation Q1 2014 I 20 May 2014 I Inv...
Strongest starting quarter in company history
3
 Strong development in Medical and Industrial Sectors
despite historicall...
Medical Sector:
Sempermed grows faster than the market
4
 Continuous strong market demand
 Examination gloves: Non-medic...
Industrial Sector:
Strong performance
5 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations
 Excellent order...
Operational Development (p. 3)
Outlook (p. 12)
Appendix (p. 15)
Agenda
6 Investor Presentation Q1 2014 I 20 May 2014 I Inv...
Excellent start in 2014
7
Q1 2014 Q1 2013 %
114.1 106.8 +6.9%
15.8 12.2 +28.9%
13.8% 11.5% +2.3 pp
9.9 7.1 +39.8%
8.7% 6.7...
Medical Sector:
On-going revenue and earnings growth
8
Q1 2014 Q1 2013 Change
Revenue in EUR m 114.1 106.8 +6.9%
EBITDA 15...
Industrial Sector:
High profitability level continues
9
Semperflex
Sempertrans
Semperform
 Double-digit volume growth
thr...
Strong cash position and very solid balance sheet
Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations10
1) ex...
Operational Development (p. 3)
Outlook (p. 12)
Appendix (p. 15)
Agenda
11 Investor Presentation Q1 2014 I 20 May 2014 I In...
Outlook 2014:
Focus on capacity expansion and organic growth
12
Satisfactory development of the Semperit Group expected
Un...
Contact and Financial Calendar
13 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations
Investor Relations
inve...
Operational Development (p. 3)
Outlook (p. 12)
Appendix (p. 15)
Agenda
14 Investor Presentation Q1 2014 I 20 May 2014 I In...
Income Statement
 Strong increase of revenue
 Decrease in material costs due to active raw
material management and lower...
Solid balance sheet structure
16
in EUR m 31.3.2014 31.12.2013 Change
Non-current assets 370.8 372.7 -0.5%
Inventories 140...
Key figures 2009-2013
17 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations
Key performance figures
in EUR m...
Upcoming SlideShare
Loading in...5
×

Investor Presentation Q1 2014

349

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
349
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Investor Presentation Q1 2014

  1. 1. 1 SEMPERIT GROUP INVESTOR PRESENTATION Q1 2014 20 May 2014
  2. 2. Operational Development (p. 3) Outlook (p. 12) Appendix (p. 15) Agenda 2 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations Financial Performance (p. 7)
  3. 3. Strongest starting quarter in company history 3  Strong development in Medical and Industrial Sectors despite historically low raw material prices  Winning market shares and new customers worldwide by stepped up sales & marketing activities  Continued globalisation of the business shows positive results  Double-digit volume growth and high capacity utilisation  Active raw material management and cost discipline help to compensate negative price effects  Revenue +8.1% to EUR 232.7m in Q1 2014  EBITDA +14.0% to EUR 33.4m, EBIT +18.9% to EUR 22.3m Q1 2014: On-going growth and high profitability Revenue by segment Q1 2014 (vs. Q1 2013) Sempermed 49% (50%) Semperform 13% (13%) Semper- trans 15% (17%) Semperflex 23% (20%) Europe 61% (60%) Asia, Africa, Others 16% (17%) North and South America 23% (23%) Revenue by region Q1 2014 (vs. Q1 2013) Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations
  4. 4. Medical Sector: Sempermed grows faster than the market 4  Continuous strong market demand  Examination gloves: Non-medical areas with high double-digit sales growth in Europe  new listings in retail chains  new accounts in industrial areas  Surgical gloves: Sales growth in Europe  High capacity utilisation Business Development Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations
  5. 5. Industrial Sector: Strong performance 5 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations  Excellent order volume, capacities are well utilised  Hydraulic hoses: Strong in Europe, rebound in the USA  Industrial hoses: Further positive results of intensified globalisation  Capacity expansion in Odry/Czech Republic on track  Sound volume development with focus on steel cord belts  Europe, South America and Africa show good order situation  Capacities well utilised until Q3 2014  Capacity expansion in Bełchatów/Poland on track Semperflex Sempertrans  Double-digit volume growth and expansion of market shares  Building profiles and industrial moulded parts with strong sales  Handrails benefit from new product line and increased efficiency  Additional shifts in Germany (building profiles) Semperform
  6. 6. Operational Development (p. 3) Outlook (p. 12) Appendix (p. 15) Agenda 6 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations Financial Performance (p. 7)
  7. 7. Excellent start in 2014 7 Q1 2014 Q1 2013 % 114.1 106.8 +6.9% 15.8 12.2 +28.9% 13.8% 11.5% +2.3 pp 9.9 7.1 +39.8% 8.7% 6.7% +2.0 pp in EUR m Revenue EBITDA EBITDA margin EBIT EBIT margin Earnings after tax Earnings per share in EUR2) CAPEX Employees (at reporting date) Medical Sector Industrial Sector Q1 2014 Q1 2013 % 118.6 108.4 +9.4% 23.2 20.3 +14.4% 19.6% 18.7% +0.9 pp 18.0 14.9 +20.5% 15.2% 13.8% +1.4 pp Q1 2014 Q1 2013 % 232.7 215.2 +8.1% 33.4 29.3 +14.0% 14.4% 13.6% +0.8 pp 22.3 18.8 +18.9% 9.6% 8.7% +0.9 pp 13.1 12.5 +5.0% 0.64 0.60 +6.7% 9.9 9.8 +1.0% 10,788 10,030 +7.6% Semperit Group1) Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations 1) Including Corporate Center costs of EUR 5.6m in Q1 2014 (EUR 3.3m in Q1 2013) 2) Attributable to the shareholders of Semperit AG Holding
  8. 8. Medical Sector: On-going revenue and earnings growth 8 Q1 2014 Q1 2013 Change Revenue in EUR m 114.1 106.8 +6.9% EBITDA 15.8 12.2 +28.9% EBITDA margin 13.8% 11.5% +2.3 pp EBIT 9.9 7.1 +39.8% EBIT margin 8.7% 6.7% +2.0 pp Higher profitability • Double-digit volume growth with strong sales in Europe and Asia • Negative price effect due to lower raw material costs • Above average earnings growth Key Financials Sempermed Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations
  9. 9. Industrial Sector: High profitability level continues 9 Semperflex Sempertrans Semperform  Double-digit volume growth through strategic customer initiatives  Economies of scale realised  Increase in profitability and earnings growth  Volume growth offset by negative raw material price effects  Good utilisation in Europe and improvements in India and China  Double-digit EBITDA- and EBIT- margin  Increased volumes in almost all business units  Slightly negative price effects  Strong results driven by active procurement and pricing policy as well as lean cost management in EUR m Q1 2014 Q1 2013 Change (%) Revenue 52.9 42.4 +24.8% EBIT 10.4 7.0 +49.4% EBIT margin 19.6% 16.4% +3.2 pp Double-digit margins in all segments in EUR m Q1 2014 Q1 2013 Change (%) Revenue 35.0 37.2 -5.7% EBIT 3.8 4.5 -15.9% EBIT margin 10.8% 12.1% -1.3 pp in EUR m Q1 2014 Q1 2013 Change (%) Revenue 30.6 28.9 +6.1% EBIT 3.8 3.5 +9.6% EBIT margin 12.4% 12.0% +0.4 pp Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations
  10. 10. Strong cash position and very solid balance sheet Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations10 1) excl. non-controlling interests 2) Q1 2013 adjusted, see notes of interim report in EUR m Q1 2014 Q1 2013 % FY 2013 Gross cash flow 27.0 28.2 -4.2% 116.2 Cash flow from operating activities 19.3 27.0 -28.2% 137.2 Cash flow from investment activities2) -8.9 -8.8 1.1% -47.8 High equity ratio Rising net liquidity Positive Cash flow from operating activities in EUR m 31.3.2014 31.12.2013 % 31.3.2013 Cash and cash equivalents 188.1 182.6 +3.1% 145.5 Corporate Schuld- schein loan and bank liabilities 136.8 139.3 -1.8% 112.6 Net liquidity 51.4 43.3 +18.7% 32.9 in EUR m 31.3.2014 31.12.2013 % 31.3.2013 Total assets 866.2 852.1 +1.7% 867.4 Equity1) 424.2 411.5 +3.1% 427.7 Equity ratio 49.0% 48.3% +0.7pp 49.3%
  11. 11. Operational Development (p. 3) Outlook (p. 12) Appendix (p. 15) Agenda 11 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations Financial Performance (p. 7)
  12. 12. Outlook 2014: Focus on capacity expansion and organic growth 12 Satisfactory development of the Semperit Group expected Unchanged growth targets  Continuation of today’s good order situation  Currently high capacity utilisation – expansions will be available as of the first half of 2015  Satisfactory development of revenue and earnings expected  CAPEX of roughly EUR 50-60 million with a focus on capacity expansion in Poland and the Czech Republic  Slight improvement of overall economic momentum  Raw material prices at historic low – no further decline to be expected  Double-digit average revenue growth 2010-2015 (CAGR)  EBITDA margin of 12 - 15%  EBIT margin of 8 - 11% Better market environment Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations
  13. 13. Contact and Financial Calendar 13 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations Investor Relations investor@semperitgroup.com +43 1 79777 - 210 www.semperitgroup.com/en/ir Modecenterstrasse 22 1031 Vienna, Austria Financial calendar 2014 of Semperit 20 May 2014 Report on Q1 2014 19 August 2014 Report on H1 2014 18 November 2014 Report on Q1-3 2014 Disclaimer The information provided in this presentation does not constitute an offer for the sale of securities nor an invitation to submit an offer to purchase shares of Semperit AG Holding, but exclusively serves information purposes. The forecasts, plans and forward-looking statements contained in this report are based on the knowledge and information available and the assessments made at the time that this report was prepared. As is true of all forward-looking statements, these statements are subject to risk and uncertainties. As a result, the actual events may deviate significantly from these expectations. No liability whatsoever is assumed for the accuracy of projections or for the achievement of planned targets or for any other forward-looking statements.
  14. 14. Operational Development (p. 3) Outlook (p. 12) Appendix (p. 15) Agenda 14 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations Financial Performance (p. 7)
  15. 15. Income Statement  Strong increase of revenue  Decrease in material costs due to active raw material management and lower raw material prices  Rise in personnel expenses due to higher number of employees (esp. Sempermed) and increased wages and salaries  Higher other operating expenses due to higher maintenance costs, outgoing freight charges and strategic projects  Negative financial result due to higher allocations of profit to redeemable non- controlling interests and financial expenses for the corporate Schuldschein loan  Tax rate rises slightly from 17.8% to 19.5% in EUR m Q1 2014 Q1 2013 Change Revenue 232.7 215.2 +8.1% Changes in inventories -2.1 8.2 – Own work capitalised 0.4 0.2 +76.7% Other operating income 6.3 6.6 -3.7% Material costs -124.2 -130.9 -5.1% Personnel expenses -41.0 -37.3 +9.9% Other operating expenses -38.7 -32.6 +18.7% EBITDA 33.4 29.3 +14.0% Depreciation and amortisation -11.1 -10.6 +5.3% EBIT 22.3 18.8 +18.9% Financial result -5.0 -3.0 +66.4% EBT 17.3 15.7 +9.7% Income taxes -4.2 -3.3 +27.8% Earnings after tax 13.1 12.5 +5.0% EPS (EUR) 0.64 0.60 +6.7% Key figures income statement Q1 2014 vs. Q1 2013 Highlights Q1 2014 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations15
  16. 16. Solid balance sheet structure 16 in EUR m 31.3.2014 31.12.2013 Change Non-current assets 370.8 372.7 -0.5% Inventories 140.7 148.4 -5.2% Trade receivables 127.5 111.2 +14.6% Other current assets incl. deferred taxes 227.2 219.7 +3.4% Total assets 866.2 852.1 +1.7% in EUR m 31.3.2014 31.12.2013 Change Equity 426.9 414.2 +3.1% Liabilities from redeemable non- controlling interests 106.6 102.4 +4.1% Provisions incl. social capital 75.4 73.7 +2.3% Corporate Schuldschein loan 125.8 125.8 – Liabilities incl. deferred taxes 131.6 136.1 -3.3% Equity & Liabilities 866.2 852.1 +1.7% Highlights Q1 2014Key figures balance sheet Q1 2014 vs. FY 2013  Balance sheet total increases primarily due to higher cash and cash equivalents and trade receivables  Lower inventories  Cash and cash equivalents rose by 3.1% or EUR 5.6m to EUR 188.1m  Trade working capital increases to EUR 199.4m (31.12.2013: EUR 186.6m) ► 21.6% of rolling 12-months-revenues (20.6% on 31.12.2013)  Equity excl. non-controlling interests stands at EUR 424.2m (total equity at 426.9m)  Liabilities and provisions almost unchanged to end of 2013 at EUR 439.3m Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations
  17. 17. Key figures 2009-2013 17 Investor Presentation Q1 2014 I 20 May 2014 I Investor Relations Key performance figures in EUR m 20091) 20101) 20111) 20121) 2013 Revenue 588.1 689.4 820.0 828.6 906.3 EBITDA 102.8 112.3 110.0 108.7 132.5 EBITDA margin 17.5% 16.3% 13.4% 13.1% 14.6% EBIT 69.6 82.3 80.4 72.5 87.8 EBIT margin 11.8% 11.9% 9.8% 8.8% 9.7% Earnings after tax 38.8 45.4 51.8 46.2 54.9 Earnings per share (EPS)2) , in EUR 1.89 2.21 2.52 2.25 2.65 Gross cash flow 92.6 91.0 89.4 85.6 116.2 Return on equity 12.5% 12.9% 13.6% 11.4% 13.3% Balance sheet key figures 2009¹ 2010¹ 2011¹ 2012 2013 Balance sheet total 531.5 593.5 616.7 824.5 852.1 Equity2) 310.6 351.1 379.4 406.2 411.5 Equity ratio 58.4% 59.2% 61.5% 49.3% 48.3% Investments in tangible and intangible assets 22.7 52.5 45.1 41.2 49.7 Employees (at balance sheet date) 6,490 7,019 8,025 9,577 10,276 1) 2011 values restated (refer to 2012 annual report, notes 2.18), values for 2009 and 2010 not restated. 2) Attributable to the shareholders of Semperit AG Holding
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×